LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LAT2 | Linker for activation of T cells family, member 2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MAP6 | Microtubule-associated protein 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MBNL3 | Muscleblind-like splicing regulator 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MKI67 | Marker of proliferation Ki-67 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NANOG | Nanog homeobox | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NEFM | Neurofilament, medium polypeptide | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NES | Nestin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PLEK | Pleckstrin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAB3B | RAB3B, member RAS oncogene family | Predicted intracellular proteins
| | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RCSD1 | RCSD domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SEPT1 | Septin 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SGOL2 | Shugoshin-like 2 (S. pombe) | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SNCA | Synuclein, alpha (non A4 component of amyloid precursor) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
SPN | Sialophorin | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
TACSTD2 | Tumor-associated calcium signal transducer 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TBX2 | T-box 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TCL1A | T-cell leukemia/lymphoma 1A | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
TPSAB1 | Tryptase alpha/beta 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TPSB2 | Tryptase beta 2 (gene/pseudogene) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
TPSD1 | Tryptase delta 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |